News & Articles

FEATURED ARTICLE

MRGPRX2: A Promising Target for Antibody Discovery in Allergy and Pain Disorders

Recent studies have shown that various drugs, including small molecules, opioids, and antibiotics, can activate MRGPRX2 (Mas-related G-protein coupled receptor X2), leading to mast cell degranulation and...

Browse articles by topic:

CD163 Protein

November 17, 2022

KACTUS offers human, mouse, and biotinylated CD163 protein.  The hemoglobin (Hb) scavenger receptor CD163, is a macrophage-specific protein involved in...

October Products

October 28, 2022

2 min read

KACTUS has developed the following new products to facilitate the latest innovations in drug development. Select a product category to...

Targeting Axl-GAS6—a new option for tumor therapy

September 12, 2022

4 min read

Tumor drug resistance is a major problem limiting the clinical efficacy of therapeutic drugs. Recently, an article published by a...

Potential Immunotherapy Target TM4SF1

September 5, 2022

5 min read

TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in the Tetraspanin superfamily. It was...

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

July 19, 2022

4 min read

Chimeric antigen receptor T cell (CAR-T) therapy has been successful in the field of hematological malignancies, but it is not...

GDF15-GFRAL breaks into the new drug track

July 12, 2022

7 min read

A variety of metabolic diseases that plague today's society, such as obesity, diabetes, cancer, etc., have yet to be solved....

The culprit of cancer metastasis - uPAR-uPA

July 7, 2022

4 min read

Tumor invasion and metastasis are key risk factors for tumor recurrence and patient death. Tumor invasion occurs when changes in...

KactusBio New Logo

March 19, 2022

2 min read

  FROM TO     Interview the graphic designer " Through the previous communication with the team and the analysis...

1 3 4 5